JCI
OPTR

Jet Capital Investors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Jet Capital Investors’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,027,589
Closed -$12.9M – 59
2013
Q3 		$12.9M Buy
+1,027,589
New +$13.6M 0.94% 30

Jet Capital Investors's OPTR Position: Q4 2013 in Review

Jet Capital Investors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,027,589 shares — an estimated $12.9M sold.

Jet Capital Investors first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $12.9M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Jet Capital Investors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Jet Capital Investors sold 1,027,589 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $12.9M.
  • Jet Capital Investors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Jet Capital Investors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $12.9M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Jet Capital Investors's 13F filing for Q4 2013, filed 14 Feb 2014.